Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma August 30, 2017 This Cancer Drug Could Bring in $3.8B for AstraZeneca January 18, 2018 Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks October 10, 2017